| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | MATN2 FAT3 EFEMP2 LRP1B CRB1 PCDHB18P SLIT2 THBS1 SLIT1 SLIT3 EDEM2 LRP1 LRP2 FBN3 NOTCH3 CRB2 | 7.03e-07 | 749 | 98 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.06e-06 | 188 | 98 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | Roundabout binding | 2.44e-05 | 12 | 98 | 3 | GO:0048495 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.13e-05 | 16 | 98 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.14e-04 | 51 | 98 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.43e-04 | 21 | 98 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | heparin binding | 3.70e-04 | 192 | 98 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 3.82e-04 | 29 | 98 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 4.58e-04 | 73 | 98 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.07e-03 | 323 | 98 | 7 | GO:1901681 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 1.04e-07 | 3 | 98 | 3 | GO:0021834 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 1.03e-06 | 5 | 98 | 3 | GO:0021831 | |
| GeneOntologyBiologicalProcess | neuron development | SFRP2 MATN2 FAT3 SAMD4B ENC1 DTNBP1 MFRP CRB1 WDR47 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 LRP2 DENND5A SULT4A1 MUSK MYO16 NOTCH3 CRB2 | 1.06e-06 | 1463 | 98 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | TCF7L2 SFRP2 OGT ZNF423 SLIT2 THBS1 CYFIP1 GLG1 LRP1 LRP2 CRB2 | 4.17e-06 | 412 | 98 | 11 | GO:0090287 |
| GeneOntologyBiologicalProcess | axon guidance | 8.70e-06 | 285 | 98 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 8.95e-06 | 286 | 98 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 1.22e-05 | 10 | 98 | 3 | GO:0022028 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 1.67e-05 | 11 | 98 | 3 | GO:0021891 | |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 2.38e-05 | 72 | 98 | 5 | GO:0022029 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential migration | 2.87e-05 | 13 | 98 | 3 | GO:0021826 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential interneuron migration | 2.87e-05 | 13 | 98 | 3 | GO:0021843 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 2.90e-05 | 75 | 98 | 5 | GO:0021885 | |
| GeneOntologyBiologicalProcess | neuron projection development | SFRP2 MATN2 FAT3 ENC1 DTNBP1 WDR47 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 LRP2 DENND5A SULT4A1 MUSK MYO16 NOTCH3 | 3.12e-05 | 1285 | 98 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4.11e-05 | 347 | 98 | 9 | GO:0090092 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | MATN2 FAT3 CASP9 DTNBP1 CRB1 WDR47 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 LRP2 SULT4A1 MYO16 EPB42 NOTCH3 | 4.36e-05 | 1194 | 98 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MATN2 FAT3 DTNBP1 WDR47 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 LRP2 SULT4A1 NOTCH3 | 5.31e-05 | 748 | 98 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | PAPPA2 TCF7L2 SFRP2 FAT3 EFEMP2 RELA MFRP ITGAX CRB1 SLIT2 THBS1 CXCR4 GLG1 SLIT1 SLIT3 LRP2 CRB2 | 9.26e-05 | 1269 | 98 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MATN2 DTNBP1 WDR47 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 LRP2 SULT4A1 MYO16 NOTCH3 | 1.07e-04 | 802 | 98 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MATN2 DTNBP1 WDR47 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 LRP2 SULT4A1 MYO16 NOTCH3 | 1.32e-04 | 819 | 98 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 1.33e-04 | 4 | 98 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MATN2 DTNBP1 WDR47 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 LRP2 SULT4A1 MYO16 NOTCH3 | 1.44e-04 | 826 | 98 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 1.50e-04 | 22 | 98 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 1.50e-04 | 22 | 98 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 1.56e-04 | 169 | 98 | 6 | GO:0010977 | |
| GeneOntologyBiologicalProcess | negative regulation of proteolysis | 1.64e-04 | 326 | 98 | 8 | GO:0045861 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | PAPPA2 SFRP2 C10orf90 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 OSGIN1 | 1.80e-04 | 519 | 98 | 10 | GO:0001558 |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | SFRP2 OGT SAMD4B ENC1 INTS1 RELA DTNBP1 IFI16 SLIT2 THBS1 CYFIP1 CNOT9 GLG1 LRP1 CRB2 | 1.84e-04 | 1088 | 98 | 15 | GO:0051248 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | TCF7L2 RELA ITGAX SLIT2 CYFIP1 CXCR4 SLIT1 LRP1 HLTF LRP2 MUSK | 1.86e-04 | 625 | 98 | 11 | GO:0051960 |
| GeneOntologyBiologicalProcess | transcytosis | 1.96e-04 | 24 | 98 | 3 | GO:0045056 | |
| GeneOntologyBiologicalProcess | brain development | TCF7L2 SFRP2 ZNF423 SAMD4B WDR47 SLIT2 CXCR4 SLIT1 SLIT3 LRP2 HYDIN MYO16 NOTCH3 | 2.11e-04 | 859 | 98 | 13 | GO:0007420 |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | PAPPA2 SFRP2 OGT DTL CASP9 RELA C10orf90 IFI16 FBXL21P CRB1 WDR47 THBS1 CYFIP1 CXCR4 LRP2 ALAS2 MUSK | 2.15e-04 | 1361 | 98 | 17 | GO:0009628 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 2.21e-04 | 5 | 98 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 2.21e-04 | 5 | 98 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron differentiation | 2.50e-04 | 26 | 98 | 3 | GO:0021889 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 2.70e-04 | 445 | 98 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of growth | PAPPA2 TCF7L2 SFRP2 C10orf90 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 MUSK OSGIN1 | 3.13e-04 | 777 | 98 | 12 | GO:0040008 |
| GeneOntologyBiologicalProcess | axonogenesis | 3.60e-04 | 566 | 98 | 10 | GO:0007409 | |
| GeneOntologyBiologicalProcess | head development | TCF7L2 SFRP2 ZNF423 SAMD4B WDR47 SLIT2 CXCR4 SLIT1 SLIT3 LRP2 HYDIN MYO16 NOTCH3 | 4.04e-04 | 919 | 98 | 13 | GO:0060322 |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 4.05e-04 | 131 | 98 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 4.06e-04 | 283 | 98 | 7 | GO:0045926 | |
| GeneOntologyBiologicalProcess | artery development | 4.34e-04 | 133 | 98 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 4.50e-04 | 134 | 98 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 4.62e-04 | 7 | 98 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | Roundabout signaling pathway | 4.62e-04 | 7 | 98 | 2 | GO:0035385 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 4.65e-04 | 207 | 98 | 6 | GO:1990138 | |
| GeneOntologyBiologicalProcess | axon extension | 4.65e-04 | 135 | 98 | 5 | GO:0048675 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 4.82e-04 | 482 | 98 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidase activity | 5.01e-04 | 210 | 98 | 6 | GO:0010466 | |
| GeneOntologyBiologicalProcess | negative regulation of cell growth | 5.27e-04 | 212 | 98 | 6 | GO:0030308 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 5.27e-04 | 212 | 98 | 6 | GO:0003205 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 5.63e-04 | 299 | 98 | 7 | GO:0060560 | |
| GeneOntologyBiologicalProcess | aorta development | 5.75e-04 | 80 | 98 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | motor neuron axon guidance | 6.10e-04 | 35 | 98 | 3 | GO:0008045 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.10e-04 | 218 | 98 | 6 | GO:0090101 | |
| GeneOntologyBiologicalProcess | response to radiation | 6.54e-04 | 503 | 98 | 9 | GO:0009314 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 6.60e-04 | 612 | 98 | 10 | GO:0010975 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 6.84e-04 | 309 | 98 | 7 | GO:1901888 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | TCF7L2 SFRP2 OGT ZNF423 RELA SLIT2 THBS1 CYFIP1 GLG1 LRP1 LRP2 CRB2 | 6.96e-04 | 850 | 98 | 12 | GO:0071363 |
| GeneOntologyBiologicalProcess | regulation of peptidase activity | 7.07e-04 | 406 | 98 | 8 | GO:0052547 | |
| GeneOntologyBiologicalProcess | negative regulation of cysteine-type endopeptidase activity | 7.23e-04 | 85 | 98 | 4 | GO:2000117 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 7.51e-04 | 150 | 98 | 5 | GO:0090288 | |
| GeneOntologyBiologicalProcess | negative regulation of endopeptidase activity | 7.73e-04 | 151 | 98 | 5 | GO:0010951 | |
| GeneOntologyBiologicalProcess | cell growth | PAPPA2 SFRP2 C10orf90 SLIT2 CYFIP1 CXCR4 SLIT1 SLIT3 LRP1 OSGIN1 | 7.76e-04 | 625 | 98 | 10 | GO:0016049 |
| GeneOntologyBiologicalProcess | regulation of collagen fibril organization | 7.87e-04 | 9 | 98 | 2 | GO:1904026 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 8.63e-04 | 233 | 98 | 6 | GO:0031345 | |
| GeneOntologyBiologicalProcess | mitotic G2 DNA damage checkpoint signaling | 9.05e-04 | 40 | 98 | 3 | GO:0007095 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 9.33e-04 | 91 | 98 | 4 | GO:0003281 | |
| GeneOntologyBiologicalProcess | axon development | 9.52e-04 | 642 | 98 | 10 | GO:0061564 | |
| GeneOntologyBiologicalProcess | regulation of cysteine-type endopeptidase activity | 9.63e-04 | 238 | 98 | 6 | GO:2000116 | |
| GeneOntologyBiologicalProcess | response to growth factor | TCF7L2 SFRP2 OGT ZNF423 RELA SLIT2 THBS1 CYFIP1 GLG1 LRP1 LRP2 CRB2 | 9.69e-04 | 883 | 98 | 12 | GO:0070848 |
| GeneOntologyBiologicalProcess | artery morphogenesis | 9.72e-04 | 92 | 98 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 9.73e-04 | 41 | 98 | 3 | GO:1901889 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine-mediated signaling pathway | 9.81e-04 | 10 | 98 | 2 | GO:0070100 | |
| GeneOntologyBiologicalProcess | positive regulation of response to wounding | 1.01e-03 | 93 | 98 | 4 | GO:1903036 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 1.03e-03 | 161 | 98 | 5 | GO:0003231 | |
| GeneOntologyBiologicalProcess | regulation of endopeptidase activity | 1.04e-03 | 332 | 98 | 7 | GO:0052548 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | TRIM72 KLHL2 OGT DTL ENC1 RELA C10orf90 ASB12 FBXL21P MEFV HLTF KBTBD13 | 1.07e-03 | 893 | 98 | 12 | GO:0032446 |
| GeneOntologyBiologicalProcess | gliogenesis | 1.10e-03 | 435 | 98 | 8 | GO:0042063 | |
| GeneOntologyBiologicalProcess | chemokine-mediated signaling pathway | 1.18e-03 | 97 | 98 | 4 | GO:0070098 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | TRIM72 TCF7L2 SFRP2 OGT ZNF423 RELA THBS1 CYFIP1 CNOT9 GLG1 LRP1 LRP2 MUSK CRB2 | 1.41e-03 | 1186 | 98 | 14 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 1.43e-03 | 12 | 98 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | sex differentiation | 1.46e-03 | 352 | 98 | 7 | GO:0007548 | |
| GeneOntologyBiologicalProcess | blood vessel development | TCF7L2 SFRP2 EFEMP2 RELA ITGAX SLIT2 THBS1 CXCR4 LRP1 LRP2 MYO18B NOTCH3 | 1.49e-03 | 929 | 98 | 12 | GO:0001568 |
| GeneOntologyBiologicalProcess | regulation of axon extension | 1.53e-03 | 104 | 98 | 4 | GO:0030516 | |
| GeneOntologyBiologicalProcess | central nervous system development | TCF7L2 SFRP2 ZNF423 SAMD4B WDR47 SLIT2 CXCR4 SLIT1 SLIT3 LRP1 LRP2 HYDIN MYO16 NOTCH3 | 1.54e-03 | 1197 | 98 | 14 | GO:0007417 |
| GeneOntologyBiologicalProcess | protein ubiquitination | TRIM72 KLHL2 OGT DTL ENC1 C10orf90 ASB12 FBXL21P MEFV HLTF KBTBD13 | 1.62e-03 | 811 | 98 | 11 | GO:0016567 |
| GeneOntologyBiologicalProcess | regulation of chemokine-mediated signaling pathway | 1.68e-03 | 13 | 98 | 2 | GO:0070099 | |
| GeneOntologyBiologicalProcess | response to chemokine | 1.70e-03 | 107 | 98 | 4 | GO:1990868 | |
| GeneOntologyBiologicalProcess | cellular response to chemokine | 1.70e-03 | 107 | 98 | 4 | GO:1990869 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | SFRP2 EFEMP2 RELA ITGAX SLIT2 THBS1 CXCR4 LRP1 LRP2 MYO18B NOTCH3 | 1.71e-03 | 817 | 98 | 11 | GO:0048514 |
| GeneOntologyCellularComponent | extracellular matrix | SFRP2 VWF MATN2 EFEMP2 COL6A5 CHADL ADAMTSL3 SLIT2 THBS1 GLG1 ADAMTS15 FBN3 | 6.31e-05 | 656 | 99 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SFRP2 VWF MATN2 EFEMP2 COL6A5 CHADL ADAMTSL3 SLIT2 THBS1 GLG1 ADAMTS15 FBN3 | 6.49e-05 | 658 | 99 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 6.76e-05 | 212 | 99 | 7 | GO:0031461 | |
| GeneOntologyCellularComponent | subapical complex | 2.20e-04 | 5 | 99 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 2.70e-04 | 352 | 99 | 8 | GO:0000151 | |
| GeneOntologyCellularComponent | SCF ubiquitin ligase complex | 3.42e-04 | 70 | 99 | 4 | GO:0019005 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | KLHL2 SPAG1 OGT TMEM183A DTL ENC1 TMEM183BP DTNBP1 ASB12 FBXL21P CNOT9 TTI1 FBXL20 | 6.66e-04 | 972 | 99 | 13 | GO:0140535 |
| GeneOntologyCellularComponent | cell surface | VWF LYZL6 CHADL ITGAX SLIT2 THBS1 CXCR4 KCNH2 ADAMTS15 LRP1 LRP2 MUSK NOTCH3 GP2 | 7.34e-04 | 1111 | 99 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | 8.00e-04 | 519 | 99 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 9.27e-04 | 530 | 99 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | growth cone | 1.10e-03 | 245 | 99 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.27e-03 | 45 | 99 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.30e-03 | 253 | 99 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | microfibril | 1.67e-03 | 13 | 99 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | transferase complex | KLHL2 OGT KMT2B TMEM183A WDR4 DTL ENC1 TMEM183BP ASB12 FBXL21P FBXL20 MED13 | 1.97e-03 | 963 | 99 | 12 | GO:1990234 |
| MousePheno | abnormal blood circulation | VWF WDR4 EFEMP2 CASP9 RELA THBS1 SETD5 CXCR4 KCNH2 SLIT3 LRP1 MYO18B HYDIN NOTCH3 GABPA | 3.49e-05 | 845 | 75 | 15 | MP:0002128 |
| MousePheno | hemorrhage | VWF WDR4 EFEMP2 CASP9 RELA THBS1 SETD5 CXCR4 SLIT3 LRP1 MYO18B HYDIN GABPA | 4.64e-05 | 664 | 75 | 13 | MP:0001914 |
| MousePheno | muscular ventricular septal defect | 5.68e-05 | 77 | 75 | 5 | MP:0010420 | |
| MousePheno | abnormal diaphragm morphology | 6.04e-05 | 78 | 75 | 5 | MP:0002279 | |
| MousePheno | abnormal interventricular septum muscular part morphology | 6.43e-05 | 79 | 75 | 5 | MP:0010498 | |
| MousePheno | abnormal thoracic aorta morphology | 8.12e-05 | 134 | 75 | 6 | MP:0010468 | |
| MousePheno | abnormal brain interventricular foramen morphology | 8.49e-05 | 3 | 75 | 2 | MP:0009804 | |
| MousePheno | perimembraneous ventricular septal defect | 1.33e-04 | 92 | 75 | 5 | MP:0010418 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 1.40e-04 | 93 | 75 | 5 | MP:0008823 | |
| MousePheno | aortic arch hypoplasia | 1.69e-04 | 4 | 75 | 2 | MP:0010485 | |
| MousePheno | abnormal muscle morphology | TRIM72 TCF7L2 FAT3 EFEMP2 RELA THBS1 RINT1 SETD5 CXCR4 SLIT3 LRP1 LRP2 KBTBD13 MYO18B MUSK NOTCH3 | 2.09e-04 | 1106 | 75 | 16 | MP:0002108 |
| MousePheno | internal hemorrhage | 2.18e-04 | 387 | 75 | 9 | MP:0001634 | |
| Domain | EGF_CA | MATN2 FAT3 EFEMP2 LRP1B CRB1 SLIT2 THBS1 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 | 2.13e-15 | 122 | 97 | 14 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | MATN2 FAT3 EFEMP2 LRP1B CRB1 SLIT2 THBS1 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 | 2.68e-15 | 124 | 97 | 14 | IPR001881 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | MATN2 FAT3 EFEMP2 LRP1B CRB1 SLIT2 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 | 9.33e-15 | 106 | 97 | 13 | IPR000152 |
| Domain | EGF_3 | MATN2 FAT3 EFEMP2 LRP1B CRB1 SLIT2 THBS1 MALRD1 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 GP2 | 7.60e-14 | 235 | 97 | 16 | PS50026 |
| Domain | EGF_Ca-bd_CS | FAT3 EFEMP2 LRP1B CRB1 SLIT2 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 | 9.47e-14 | 97 | 97 | 12 | IPR018097 |
| Domain | EGF_CA | FAT3 EFEMP2 LRP1B CRB1 SLIT2 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 | 1.22e-13 | 99 | 97 | 12 | PS01187 |
| Domain | EGF-like_dom | MATN2 FAT3 EFEMP2 LRP1B CRB1 SLIT2 THBS1 MALRD1 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 GP2 | 1.86e-13 | 249 | 97 | 16 | IPR000742 |
| Domain | EGF-like_CS | MATN2 FAT3 EFEMP2 LRP1B CRB1 SLIT2 THBS1 MALRD1 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 GP2 | 3.86e-13 | 261 | 97 | 16 | IPR013032 |
| Domain | EGF_2 | MATN2 FAT3 EFEMP2 LRP1B CRB1 SLIT2 THBS1 MALRD1 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 GP2 | 4.87e-13 | 265 | 97 | 16 | PS01186 |
| Domain | EGF | MATN2 FAT3 EFEMP2 LRP1B CRB1 SLIT2 THBS1 MALRD1 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 | 1.24e-12 | 235 | 97 | 15 | SM00181 |
| Domain | EGF | MATN2 LRP1B CRB1 SLIT2 MALRD1 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 | 2.29e-12 | 126 | 97 | 12 | PF00008 |
| Domain | ASX_HYDROXYL | MATN2 FAT3 EFEMP2 LRP1B CRB1 SLIT2 LRP1 LRP2 FBN3 NOTCH3 CRB2 | 4.01e-12 | 100 | 97 | 11 | PS00010 |
| Domain | EGF_1 | FAT3 EFEMP2 LRP1B CRB1 SLIT2 THBS1 MALRD1 SLIT1 SLIT3 LRP1 LRP2 FBN3 NOTCH3 CRB2 GP2 | 4.04e-12 | 255 | 97 | 15 | PS00022 |
| Domain | EGF_CA | 6.23e-10 | 86 | 97 | 9 | PF07645 | |
| Domain | cEGF | 3.55e-09 | 26 | 97 | 6 | IPR026823 | |
| Domain | cEGF | 3.55e-09 | 26 | 97 | 6 | PF12662 | |
| Domain | hEGF | 5.76e-09 | 28 | 97 | 6 | PF12661 | |
| Domain | Growth_fac_rcpt_ | 8.34e-09 | 156 | 97 | 10 | IPR009030 | |
| Domain | ConA-like_dom | TRIM72 PAPPA2 FAT3 MEFV CRB1 SLIT2 THBS1 MALRD1 SLIT1 SLIT3 CRB2 | 1.84e-08 | 219 | 97 | 11 | IPR013320 |
| Domain | Laminin_G | 1.98e-08 | 58 | 97 | 7 | IPR001791 | |
| Domain | - | 3.31e-08 | 95 | 97 | 8 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 4.05e-08 | 38 | 97 | 6 | PS50025 | |
| Domain | Laminin_G_2 | 5.59e-08 | 40 | 97 | 6 | PF02210 | |
| Domain | LamG | 1.01e-07 | 44 | 97 | 6 | SM00282 | |
| Domain | LDLR_class-A_CS | 1.94e-06 | 40 | 97 | 5 | IPR023415 | |
| Domain | CTCK_1 | 1.98e-06 | 18 | 97 | 4 | PS01185 | |
| Domain | Ldl_recept_a | 3.53e-06 | 45 | 97 | 5 | PF00057 | |
| Domain | - | 3.94e-06 | 46 | 97 | 5 | 4.10.400.10 | |
| Domain | CT | 4.65e-06 | 22 | 97 | 4 | SM00041 | |
| Domain | LDLRA_1 | 4.89e-06 | 48 | 97 | 5 | PS01209 | |
| Domain | LDLRA_2 | 5.42e-06 | 49 | 97 | 5 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 5.42e-06 | 49 | 97 | 5 | IPR002172 | |
| Domain | LDLa | 5.42e-06 | 49 | 97 | 5 | SM00192 | |
| Domain | Cys_knot_C | 7.95e-06 | 25 | 97 | 4 | IPR006207 | |
| Domain | CTCK_2 | 7.95e-06 | 25 | 97 | 4 | PS01225 | |
| Domain | TMEM183 | 2.67e-05 | 2 | 97 | 2 | IPR026509 | |
| Domain | DUF5050 | 2.67e-05 | 2 | 97 | 2 | IPR032485 | |
| Domain | DUF5050 | 2.67e-05 | 2 | 97 | 2 | PF16472 | |
| Domain | - | 4.44e-05 | 321 | 97 | 9 | 3.80.10.10 | |
| Domain | Ldl_recept_b | 4.74e-05 | 14 | 97 | 3 | PF00058 | |
| Domain | LDLRB | 4.74e-05 | 14 | 97 | 3 | PS51120 | |
| Domain | L_dom-like | 5.25e-05 | 328 | 97 | 9 | IPR032675 | |
| Domain | LY | 5.91e-05 | 15 | 97 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.91e-05 | 15 | 97 | 3 | IPR000033 | |
| Domain | Leu-rich_rpt | 8.40e-05 | 271 | 97 | 8 | IPR001611 | |
| Domain | - | 1.69e-04 | 21 | 97 | 3 | 1.10.2000.10 | |
| Domain | DAPIN | 1.95e-04 | 22 | 97 | 3 | PS50824 | |
| Domain | PYRIN | 1.95e-04 | 22 | 97 | 3 | PF02758 | |
| Domain | DAPIN | 1.95e-04 | 22 | 97 | 3 | IPR004020 | |
| Domain | PYRIN | 1.95e-04 | 22 | 97 | 3 | SM01289 | |
| Domain | VWA | 2.04e-04 | 56 | 97 | 4 | PF00092 | |
| Domain | Frizzled_dom | 2.54e-04 | 24 | 97 | 3 | IPR020067 | |
| Domain | FZ | 2.54e-04 | 24 | 97 | 3 | PS50038 | |
| Domain | Fz | 2.54e-04 | 24 | 97 | 3 | PF01392 | |
| Domain | LRR_8 | 2.68e-04 | 171 | 97 | 6 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.22e-04 | 177 | 97 | 6 | IPR003591 | |
| Domain | LRR_TYP | 3.22e-04 | 177 | 97 | 6 | SM00369 | |
| Domain | Notch_dom | 5.51e-04 | 7 | 97 | 2 | IPR000800 | |
| Domain | Notch | 5.51e-04 | 7 | 97 | 2 | PF00066 | |
| Domain | NL | 5.51e-04 | 7 | 97 | 2 | SM00004 | |
| Domain | LRRCT | 6.04e-04 | 32 | 97 | 3 | PF01463 | |
| Domain | F-box_dom | 6.27e-04 | 75 | 97 | 4 | IPR001810 | |
| Domain | LRR | 6.32e-04 | 201 | 97 | 6 | PS51450 | |
| Domain | VWFA | 8.77e-04 | 82 | 97 | 4 | PS50234 | |
| Domain | VWA | 9.60e-04 | 84 | 97 | 4 | SM00327 | |
| Domain | LRR_1 | 9.88e-04 | 219 | 97 | 6 | PF00560 | |
| Domain | - | 1.08e-03 | 39 | 97 | 3 | 2.120.10.30 | |
| Domain | Cys-rich_flank_reg_C | 1.24e-03 | 90 | 97 | 4 | IPR000483 | |
| Domain | LRRCT | 1.24e-03 | 90 | 97 | 4 | SM00082 | |
| Domain | Fol_N | 1.42e-03 | 11 | 97 | 2 | IPR003645 | |
| Domain | FOLN | 1.42e-03 | 11 | 97 | 2 | SM00274 | |
| Domain | LRRNT | 1.70e-03 | 98 | 97 | 4 | IPR000372 | |
| Domain | LRRNT | 1.70e-03 | 98 | 97 | 4 | SM00013 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.75e-03 | 46 | 97 | 3 | IPR011042 | |
| Domain | DEATH-like_dom | 1.77e-03 | 99 | 97 | 4 | IPR011029 | |
| Domain | VWF_A | 1.77e-03 | 99 | 97 | 4 | IPR002035 | |
| Domain | TIL_dom | 2.33e-03 | 14 | 97 | 2 | IPR002919 | |
| Domain | uDENN | 2.33e-03 | 14 | 97 | 2 | SM00800 | |
| Domain | LRRNT | 2.64e-03 | 53 | 97 | 3 | PF01462 | |
| Domain | uDENN | 2.68e-03 | 15 | 97 | 2 | PF03456 | |
| Domain | LRR_6 | 2.93e-03 | 55 | 97 | 3 | PF13516 | |
| Domain | UDENN | 3.06e-03 | 16 | 97 | 2 | PS50946 | |
| Domain | DDENN | 3.06e-03 | 16 | 97 | 2 | PS50947 | |
| Domain | DENN | 3.06e-03 | 16 | 97 | 2 | SM00799 | |
| Domain | dDENN | 3.06e-03 | 16 | 97 | 2 | SM00801 | |
| Domain | DENN | 3.06e-03 | 16 | 97 | 2 | PF02141 | |
| Domain | dDENN_dom | 3.06e-03 | 16 | 97 | 2 | IPR005112 | |
| Domain | uDENN_dom | 3.06e-03 | 16 | 97 | 2 | IPR005113 | |
| Domain | dDENN | 3.06e-03 | 16 | 97 | 2 | PF03455 | |
| Domain | DENN | 3.06e-03 | 16 | 97 | 2 | PS50211 | |
| Domain | DENN_dom | 3.06e-03 | 16 | 97 | 2 | IPR001194 | |
| Domain | Kelch | 3.41e-03 | 58 | 97 | 3 | SM00612 | |
| Domain | EGF_extracell | 3.75e-03 | 60 | 97 | 3 | IPR013111 | |
| Domain | EGF_2 | 3.75e-03 | 60 | 97 | 3 | PF07974 | |
| Domain | RUN | 3.87e-03 | 18 | 97 | 2 | SM00593 | |
| Domain | TSP_1 | 4.30e-03 | 63 | 97 | 3 | PF00090 | |
| Domain | RUN | 4.31e-03 | 19 | 97 | 2 | PS50826 | |
| Domain | RUN | 4.31e-03 | 19 | 97 | 2 | PF02759 | |
| Domain | Run_dom | 4.31e-03 | 19 | 97 | 2 | IPR004012 | |
| Domain | TPR | 4.59e-03 | 129 | 97 | 4 | SM00028 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 1.76e-05 | 10 | 76 | 3 | M27348 | |
| Pubmed | SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. | 9.61e-10 | 6 | 100 | 4 | 18829537 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 9813312 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 16840550 | ||
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 2.31e-08 | 3 | 100 | 3 | 24065825 | |
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 2.31e-08 | 3 | 100 | 3 | 16162649 | |
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 2.31e-08 | 3 | 100 | 3 | 12141424 | |
| Pubmed | Slits contribute to the guidance of retinal ganglion cell axons in the mammalian optic tract. | 9.21e-08 | 4 | 100 | 3 | 16828733 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 7775583 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 10433822 | ||
| Pubmed | On the topographic targeting of basal vomeronasal axons through Slit-mediated chemorepulsion. | 2.30e-07 | 5 | 100 | 3 | 12954717 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 28234971 | ||
| Pubmed | Slit proteins are not dominant chemorepellents for olfactory tract and spinal motor axons. | 2.30e-07 | 5 | 100 | 3 | 11748139 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 12609596 | ||
| Pubmed | Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding. | 2.30e-07 | 5 | 100 | 3 | 15207848 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 11520671 | ||
| Pubmed | The transcription factor neurogenin 2 restricts cell migration from the cortex to the striatum. | 3.01e-07 | 20 | 100 | 4 | 11748150 | |
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 10864954 | ||
| Pubmed | Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. | 4.58e-07 | 6 | 100 | 3 | 22306607 | |
| Pubmed | Slit/Robo-mediated chemorepulsion of vagal sensory axons in the fetal gut. | 4.58e-07 | 6 | 100 | 3 | 23161783 | |
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 16439476 | ||
| Pubmed | Pioneer longitudinal axons navigate using floor plate and Slit/Robo signals. | 4.58e-07 | 6 | 100 | 3 | 18842816 | |
| Pubmed | Robo2 Receptor Gates the Anatomical Divergence of Neurons Derived From a Common Precursor Origin. | 4.58e-07 | 6 | 100 | 3 | 34249921 | |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 21688288 | ||
| Pubmed | Slit molecules prevent entrance of trunk neural crest cells in developing gut. | 8.01e-07 | 7 | 100 | 3 | 25490618 | |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 20606719 | ||
| Pubmed | Robo1 modulates proliferation and neurogenesis in the developing neocortex. | 1.07e-06 | 27 | 100 | 4 | 24741061 | |
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 23884932 | ||
| Pubmed | Multiple Slits regulate the development of midline glial populations and the corpus callosum. | 1.28e-06 | 8 | 100 | 3 | 22349628 | |
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 1.28e-06 | 8 | 100 | 3 | 25485759 | |
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 17581972 | ||
| Pubmed | Conserved roles for Slit and Robo proteins in midline commissural axon guidance. | 1.28e-06 | 8 | 100 | 3 | 15091338 | |
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 15162513 | ||
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 10864955 | ||
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 25056828 | ||
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 22806432 | ||
| Pubmed | Collaborative and specialized functions of Robo1 and Robo2 in spinal commissural axon guidance. | 1.91e-06 | 9 | 100 | 3 | 20631173 | |
| Pubmed | Robo signalling controls pancreatic progenitor identity by regulating Tead transcription factors. | 2.79e-06 | 34 | 100 | 4 | 30504829 | |
| Pubmed | 2.98e-06 | 214 | 100 | 7 | 22199357 | ||
| Pubmed | Molecular mechanisms controlling midline crossing by precerebellar neurons. | 3.74e-06 | 11 | 100 | 3 | 18562598 | |
| Pubmed | 3.74e-06 | 11 | 100 | 3 | 22399681 | ||
| Pubmed | 3.74e-06 | 11 | 100 | 3 | 24639464 | ||
| Pubmed | Knockdown of slit signaling during limb development leads to a reduction in humerus length. | 3.74e-06 | 11 | 100 | 3 | 33347679 | |
| Pubmed | OGT VWF WDR4 ZNF423 EFEMP2 ENC1 LRP1B WDR47 ZNF34 THBS1 LRP1 LRP2 SULT4A1 MED13 DOP1B | 4.02e-06 | 1285 | 100 | 15 | 35914814 | |
| Pubmed | Roundabout receptors are critical for foregut separation from the body wall. | 4.98e-06 | 12 | 100 | 3 | 23328398 | |
| Pubmed | 4.98e-06 | 12 | 100 | 3 | 22981605 | ||
| Pubmed | Sim1 and Sim2 are required for the correct targeting of mammillary body axons. | 4.98e-06 | 12 | 100 | 3 | 16291793 | |
| Pubmed | 4.98e-06 | 12 | 100 | 3 | 19906969 | ||
| Pubmed | Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons. | 6.46e-06 | 13 | 100 | 3 | 23534961 | |
| Pubmed | Expression of Slit and Robo genes in the developing mouse heart. | 6.46e-06 | 13 | 100 | 3 | 20941780 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 19700621 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 7.84e-06 | 248 | 100 | 7 | 24006456 | |
| Pubmed | Crumbs proteins regulate layered retinal vascular development required for vision. | 8.18e-06 | 2 | 100 | 2 | 31718797 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 8.18e-06 | 2 | 100 | 2 | 15963947 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 14991768 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12690099 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23603903 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35069585 | ||
| Pubmed | Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice. | 8.18e-06 | 2 | 100 | 2 | 14981081 | |
| Pubmed | Targeted ablation of CRB1 and CRB2 in retinal progenitor cells mimics Leber congenital amaurosis. | 8.18e-06 | 2 | 100 | 2 | 24339791 | |
| Pubmed | The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity. | 8.18e-06 | 2 | 100 | 2 | 36116131 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9045712 | ||
| Pubmed | Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer. | 8.18e-06 | 2 | 100 | 2 | 38696842 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28681591 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17154366 | ||
| Pubmed | Thrombospondin 1 requires von Willebrand factor to modulate arterial thrombosis in mice. | 8.18e-06 | 2 | 100 | 2 | 25343959 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24877199 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30956116 | ||
| Pubmed | CRB2 acts as a modifying factor of CRB1-related retinal dystrophies in mice. | 8.18e-06 | 2 | 100 | 2 | 24565864 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21518247 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 29893966 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34445520 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12515855 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18855616 | ||
| Pubmed | Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup. | 8.18e-06 | 2 | 100 | 2 | 16644869 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30076417 | ||
| Pubmed | Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. | 8.18e-06 | 2 | 100 | 2 | 12200164 | |
| Pubmed | Human CRB1 and CRB2 form homo- and heteromeric protein complexes in the retina. | 8.18e-06 | 2 | 100 | 2 | 38570189 | |
| Pubmed | Directional guidance of neuronal migration in the olfactory system by the protein Slit. | 8.18e-06 | 2 | 100 | 2 | 10432110 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22301903 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25393517 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23320558 | ||
| Pubmed | Slit1 and slit2 proteins control the development of the lateral olfactory tract. | 8.18e-06 | 2 | 100 | 2 | 12097499 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 39284539 | ||
| Pubmed | MG53 suppresses NF-κB activation to mitigate age-related heart failure. | 8.18e-06 | 2 | 100 | 2 | 34292883 | |
| Pubmed | 8.20e-06 | 14 | 100 | 3 | 15082773 | ||
| Pubmed | 1.02e-05 | 15 | 100 | 3 | 23821580 | ||
| Pubmed | A simple method for 3D analysis of immunolabeled axonal tracts in a transparent nervous system. | 1.02e-05 | 15 | 100 | 3 | 25456121 | |
| Pubmed | 1.02e-05 | 15 | 100 | 3 | 23255421 | ||
| Pubmed | 1.02e-05 | 15 | 100 | 3 | 18345009 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.08e-05 | 100 | 100 | 5 | 25807483 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.13e-05 | 101 | 100 | 5 | 23382219 | |
| Pubmed | 1.26e-05 | 16 | 100 | 3 | 17715346 | ||
| Pubmed | 1.26e-05 | 16 | 100 | 3 | 26527618 | ||
| Pubmed | Sensory and spinal inhibitory dorsal midline crossing is independent of Robo3. | 1.52e-05 | 17 | 100 | 3 | 26257608 | |
| Pubmed | 1.52e-05 | 17 | 100 | 3 | 23292680 | ||
| Pubmed | 1.82e-05 | 18 | 100 | 3 | 16854408 | ||
| Pubmed | ISL1-based LIM complexes control Slit2 transcription in developing cranial motor neurons. | 1.82e-05 | 18 | 100 | 3 | 27819291 | |
| Pubmed | Non-cell autonomous control of precerebellar neuron migration by Slit and Robo proteins. | 2.16e-05 | 19 | 100 | 3 | 29343636 | |
| Pubmed | 2.16e-05 | 19 | 100 | 3 | 25691540 | ||
| Pubmed | Ezh2 orchestrates topographic migration and connectivity of mouse precerebellar neurons. | 2.16e-05 | 19 | 100 | 3 | 23307742 | |
| GeneFamily | Low density lipoprotein receptors | 1.48e-05 | 13 | 69 | 3 | 634 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 1.15e-04 | 25 | 69 | 3 | 994 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 5.08e-04 | 9 | 69 | 2 | 1223 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 9.77e-04 | 115 | 69 | 4 | 769 | |
| GeneFamily | F-box and leucine rich repeat proteins | 2.88e-03 | 21 | 69 | 2 | 558 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.07e-03 | 25 | 69 | 2 | 504 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | SPAG1 SFRP2 FAT3 EFEMP2 MFRP LRP1B CRB1 SLIT2 SLIT1 OSBPL6 LRP1 LRP2 HYDIN CRB2 | 3.43e-08 | 574 | 99 | 14 | M39056 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | SPAG1 SFRP2 FAT3 EFEMP2 MFRP CRB1 CXCR4 SLIT1 OSBPL6 LRP1 LRP2 PHLPP1 HYDIN CRB2 | 5.94e-08 | 600 | 99 | 14 | M39055 |
| Coexpression | NABA_CORE_MATRISOME | 9.41e-08 | 275 | 99 | 10 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.11e-07 | 196 | 99 | 8 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 8.82e-07 | 270 | 99 | 9 | MM17057 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.26e-06 | 191 | 99 | 7 | MM17059 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P7 | 2.50e-05 | 91 | 99 | 5 | M1736 | |
| Coexpression | NABA_MATRISOME | PAPPA2 SFRP2 VWF MATN2 EFEMP2 COL6A5 CHADL MFRP ADAMTSL3 SLIT2 THBS1 SLIT1 SLIT3 ADAMTS15 | 2.57e-05 | 1008 | 99 | 14 | MM17056 |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P7 | 2.77e-05 | 93 | 99 | 5 | MM1218 | |
| Coexpression | NABA_MATRISOME | PAPPA2 SFRP2 VWF MATN2 EFEMP2 COL6A5 CHADL ADAMTSL3 SLIT2 THBS1 SLIT1 SLIT3 ADAMTS15 FBN3 | 3.11e-05 | 1026 | 99 | 14 | M5889 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 4.37e-05 | 439 | 99 | 9 | M39054 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 1.11e-04 | 199 | 99 | 6 | M6645 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.14e-04 | 200 | 99 | 6 | M5930 | |
| Coexpression | GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP | 1.14e-04 | 200 | 99 | 6 | M7424 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.88e-09 | 170 | 100 | 8 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-08 | 192 | 100 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-08 | 192 | 100 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-08 | 194 | 100 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-08 | 194 | 100 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.67e-08 | 199 | 100 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.67e-08 | 199 | 100 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.67e-08 | 199 | 100 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | (5)_Fibroblast-F|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.67e-08 | 199 | 100 | 8 | 1f66db4f502de4a5159cde90fcb3befb26b8d375 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-07 | 189 | 100 | 7 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-07 | 189 | 100 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-07 | 189 | 100 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-07 | 190 | 100 | 7 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-07 | 190 | 100 | 7 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-07 | 191 | 100 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-07 | 192 | 100 | 7 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-07 | 192 | 100 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-07 | 192 | 100 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-07 | 192 | 100 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.64e-07 | 192 | 100 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-07 | 192 | 100 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-07 | 193 | 100 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.74e-07 | 193 | 100 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-07 | 199 | 100 | 7 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-07 | 199 | 100 | 7 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-07 | 199 | 100 | 7 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.37e-07 | 199 | 100 | 7 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.37e-07 | 199 | 100 | 7 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.37e-07 | 199 | 100 | 7 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.37e-07 | 199 | 100 | 7 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 100 | 7 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 100 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.92e-07 | 125 | 100 | 6 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 160 | 100 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 160 | 100 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 169 | 100 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-06 | 171 | 100 | 6 | a474aaed3ca4cacb0ab565c35f25d92a10f531b7 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 2.53e-06 | 172 | 100 | 6 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-06 | 175 | 100 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.29e-06 | 180 | 100 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.29e-06 | 180 | 100 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.51e-06 | 182 | 100 | 6 | 1adb8d6404d50155e9f9ba805abef63929fe865f | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.62e-06 | 183 | 100 | 6 | b52d7683dc6652766e814ebe935c264ecd610c4b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.62e-06 | 183 | 100 | 6 | 1d77d8d8c8f78f43dd8864e76f294ee66d4942c2 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_reticulocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.62e-06 | 183 | 100 | 6 | 5470e5ac3439cfc96acd2202f6b1e386779a6637 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 183 | 100 | 6 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 184 | 100 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 184 | 100 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 184 | 100 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.85e-06 | 185 | 100 | 6 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 186 | 100 | 6 | ff6ccfdf2509f96caa10281c29a95b432f6c6dcc | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.98e-06 | 186 | 100 | 6 | 40acd9b4e9b3c1d1527bd4ba17ae830ff18d6e9d | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 4.10e-06 | 187 | 100 | 6 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.23e-06 | 188 | 100 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.49e-06 | 190 | 100 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.49e-06 | 190 | 100 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | severe_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 4.77e-06 | 192 | 100 | 6 | 1b4e28fd2e3d70ab48dbe96b280d35395889fbe2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-06 | 192 | 100 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-06 | 192 | 100 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.77e-06 | 192 | 100 | 6 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-06 | 194 | 100 | 6 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-06 | 194 | 100 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.06e-06 | 194 | 100 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.22e-06 | 195 | 100 | 6 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 195 | 100 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 195 | 100 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 195 | 100 | 6 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.22e-06 | 195 | 100 | 6 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.37e-06 | 196 | 100 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.37e-06 | 196 | 100 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 5.53e-06 | 197 | 100 | 6 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.53e-06 | 197 | 100 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 198 | 100 | 6 | 0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-06 | 198 | 100 | 6 | abac765c4f6864bdb1700bc546c3b9771edc25c3 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.69e-06 | 198 | 100 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.69e-06 | 198 | 100 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-06 | 198 | 100 | 6 | ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-06 | 198 | 100 | 6 | 698166b4ca173176ed563af6a1efc8c7d0a18e0b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-06 | 199 | 100 | 6 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-06 | 199 | 100 | 6 | 59fe5f3c6338e019a149ab135acf9cc5657298bf | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-06 | 199 | 100 | 6 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 199 | 100 | 6 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.86e-06 | 199 | 100 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-06 | 199 | 100 | 6 | 136f24597ddca5cf2175120975c94782a3232ec6 | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.86e-06 | 199 | 100 | 6 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 6.03e-06 | 200 | 100 | 6 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 200 | 100 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 200 | 100 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-06 | 200 | 100 | 6 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| Computational | Metal / Ca ion binding. | 1.22e-04 | 133 | 63 | 6 | MODULE_324 | |
| Disease | Schizophrenia | TCF7L2 RELA DTNBP1 ADAMTSL3 FBXL21P THBS1 CYFIP1 KCNH2 SLIT3 EDEM2 LRP1 LRP2 SULT4A1 MYO16 | 9.01e-07 | 883 | 95 | 14 | C0036341 |
| Disease | pulse pressure measurement | PAPPA2 TCF7L2 ZNF423 FAT3 ADAMTSL3 CYFIP1 TRANK1 MALRD1 SLIT1 SLIT3 ADAMTS15 LRP1 MCF2L HYDIN MUSK NOTCH3 | 8.99e-06 | 1392 | 95 | 16 | EFO_0005763 |
| Disease | response to docetaxel trihydrate | 1.03e-05 | 2 | 95 | 2 | GO_1902519 | |
| Disease | cortical thickness | TCF7L2 KMT2B ZNF423 FAT3 TTC34 ADAMTSL3 SLIT2 THBS1 MALRD1 SETD5 LRP1 MUSK MYO16 CRB2 | 1.29e-05 | 1113 | 95 | 14 | EFO_0004840 |
| Disease | vital capacity | PAPPA2 TCF20 ADAMTSL3 THBS1 CXCR4 OSBPL6 ADAMTS15 LRP2 XYLB MYO18B FBXL20 MUSK MYO16 FBN3 | 4.09e-05 | 1236 | 95 | 14 | EFO_0004312 |
| Disease | arecaidine measurement | 1.02e-04 | 5 | 95 | 2 | EFO_0801112 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.36e-04 | 31 | 95 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 1.53e-04 | 6 | 95 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | IGF-1 measurement | 1.83e-04 | 488 | 95 | 8 | EFO_0004627 | |
| Disease | bipolar II disorder | 2.84e-04 | 8 | 95 | 2 | EFO_0009964 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 2.84e-04 | 8 | 95 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | free cholesterol change measurement, high density lipoprotein cholesterol measurement | 2.84e-04 | 8 | 95 | 2 | EFO_0004612, EFO_0020905 | |
| Disease | Pena-Shokeir syndrome type I | 2.84e-04 | 8 | 95 | 2 | C1276035 | |
| Disease | diastolic blood pressure, self reported educational attainment | 2.84e-04 | 8 | 95 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | Retinal Pigment Epithelial Detachment | 3.64e-04 | 9 | 95 | 2 | C0339546 | |
| Disease | lower face morphology measurement | 4.33e-04 | 109 | 95 | 4 | EFO_0010948 | |
| Disease | leptin measurement, sex interaction measurement | 4.54e-04 | 10 | 95 | 2 | EFO_0005000, EFO_0008343 | |
| Disease | Retinal Detachment | 5.54e-04 | 11 | 95 | 2 | C0035305 | |
| Disease | Microphthalmos | 5.54e-04 | 11 | 95 | 2 | C0026010 | |
| Disease | Sodium measurement | 5.54e-04 | 11 | 95 | 2 | C0337443 | |
| Disease | Adverse Event by CTCAE Category | 5.54e-04 | 11 | 95 | 2 | C1879645 | |
| Disease | sitting height ratio | 6.02e-04 | 51 | 95 | 3 | EFO_0007118 | |
| Disease | neuroimaging measurement | TCF7L2 SFRP2 KMT2B FAT3 TTC34 SLIT2 THBS1 CXCR4 FBXL20 MUSK MYO16 | 6.50e-04 | 1069 | 95 | 11 | EFO_0004346 |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 6.63e-04 | 12 | 95 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | body weight | PAPPA2 TCF7L2 ZNF423 DTL ADAMTSL3 LRP1B CRB1 SLIT2 KCNH2 SLIT1 SLIT3 GP2 | 7.29e-04 | 1261 | 95 | 12 | EFO_0004338 |
| Disease | Migraine Disorders | 7.82e-04 | 13 | 95 | 2 | C0149931 | |
| Disease | Proteinuria | 1.05e-03 | 15 | 95 | 2 | HP_0000093 | |
| Disease | Neoplastic Cell Transformation | 1.08e-03 | 139 | 95 | 4 | C0007621 | |
| Disease | Barrett Epithelium | 1.20e-03 | 16 | 95 | 2 | C1258085 | |
| Disease | Diabetic Angiopathies | 1.20e-03 | 16 | 95 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 1.20e-03 | 16 | 95 | 2 | C0025945 | |
| Disease | osteosarcoma (is_implicated_in) | 1.20e-03 | 16 | 95 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | Barrett Esophagus | 1.20e-03 | 16 | 95 | 2 | C0004763 | |
| Disease | Muscle hypotonia | 1.35e-03 | 17 | 95 | 2 | C0026827 | |
| Disease | heart disease (biomarker_via_orthology) | 1.35e-03 | 17 | 95 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.35e-03 | 17 | 95 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | bipolar disorder, sex interaction measurement | 1.52e-03 | 18 | 95 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | spine bone size | 1.52e-03 | 18 | 95 | 2 | EFO_0004508 | |
| Disease | Paroxysmal atrial fibrillation | 1.65e-03 | 156 | 95 | 4 | C0235480 | |
| Disease | prostate cancer (is_marker_for) | 1.65e-03 | 156 | 95 | 4 | DOID:10283 (is_marker_for) | |
| Disease | familial atrial fibrillation | 1.65e-03 | 156 | 95 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.65e-03 | 156 | 95 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 1.81e-03 | 160 | 95 | 4 | C0004238 | |
| Disease | coagulation factor measurement | 1.88e-03 | 20 | 95 | 2 | EFO_0004634 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 1.88e-03 | 20 | 95 | 2 | DOID:3328 (is_marker_for) | |
| Disease | brain connectivity measurement | 1.88e-03 | 400 | 95 | 6 | EFO_0005210 | |
| Disease | epilepsy (implicated_via_orthology) | 1.93e-03 | 163 | 95 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | osteoarthritis (biomarker_via_orthology) | 2.07e-03 | 21 | 95 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | treatment resistant depression, response to antidepressant | 2.07e-03 | 21 | 95 | 2 | EFO_0009854, GO_0036276 | |
| Disease | prothrombin time measurement | 2.07e-03 | 21 | 95 | 2 | EFO_0008390 | |
| Disease | leptin measurement | 2.30e-03 | 81 | 95 | 3 | EFO_0005000 | |
| Disease | BMI-adjusted fasting blood glucose measurement | 2.48e-03 | 23 | 95 | 2 | EFO_0008036 | |
| Disease | waist circumference | 2.67e-03 | 429 | 95 | 6 | EFO_0004342 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 2.70e-03 | 24 | 95 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | blood tin measurement | 2.93e-03 | 25 | 95 | 2 | EFO_0021530 | |
| Disease | pallidum volume change measurement, age at assessment | 2.93e-03 | 25 | 95 | 2 | EFO_0008007, EFO_0021494 | |
| Disease | age at menarche | 3.11e-03 | 594 | 95 | 7 | EFO_0004703 | |
| Disease | diffuse plaque measurement | 3.12e-03 | 758 | 95 | 8 | EFO_0010699 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 3.17e-03 | 26 | 95 | 2 | DOID:9351 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SCFAQEDIAICRPHL | 576 | P16452 | |
| ITEALAFFHCCLNPI | 286 | P61073 | |
| CNALALLQCVASHPE | 91 | Q92600 | |
| CHSCNLLDDSALPFF | 51 | Q16570 | |
| EYNDAISAHCNLCLP | 356 | Q8N9N2 | |
| ELDGQVENLHLDLCC | 576 | Q9NZJ0 | |
| TDDNECHAQPDLCVN | 2251 | Q75N90 | |
| DQCNLHRKPQELDFC | 931 | Q8TE58 | |
| HCENFNLLLPSCVED | 711 | P20702 | |
| LCDLTEPCILHFQVL | 41 | Q96TA0 | |
| AHDEFRCDQLICLLP | 261 | Q9BY79 | |
| LEEVCDLLHAAPFQN | 1016 | Q7L576 | |
| NHLLNSLPCVDYLEC | 321 | Q5SY16 | |
| DRDQQLCDPGEFLCH | 26 | Q9NZR2 | |
| DHGCEQLCLNTEDSF | 451 | O00339 | |
| ENLCHVDCQDLLNPN | 91 | O75951 | |
| PVQCLCEFLLHDAVD | 906 | Q8N201 | |
| HIACACDNPDIVLLL | 131 | Q9Y6X6 | |
| CQLDLDECQSQPCAH | 181 | Q5IJ48 | |
| CSLDAHEICLQDIQL | 61 | Q06546 | |
| HTSENLCCRTFDEPL | 326 | A6NM62 | |
| DNSDEANCDIHVCLP | 3401 | Q07954 | |
| TLLEICLHHNCEPEY | 216 | Q8WXK4 | |
| PSHDLQELSNEENCC | 1131 | Q9Y3R5 | |
| QAPRLAENFCVCHLA | 31 | P54819 | |
| FLQENPSCLLCNILH | 2096 | Q2LD37 | |
| PECLQADICLHLNRS | 721 | Q12809 | |
| DPAALHCCQRLKEEQ | 481 | Q9BV94 | |
| LPTCGNNILDHFLCE | 166 | Q9Y3N9 | |
| NLLHLEDLCGQCELE | 131 | Q96EV8 | |
| CEIHLCDSLNEQCQP | 461 | P55259 | |
| IDNRLCLQSPENDHC | 1586 | Q9UM47 | |
| CLIIANPLCSDSHAE | 411 | A8MYU2 | |
| AFSHLEDPRQCALCL | 1571 | Q9UMN6 | |
| SDEELHLCLDVPCNS | 3871 | P98164 | |
| LDINECEQFGTCPQH | 4006 | P98164 | |
| QVQLLFCEDHDEPIC | 381 | O15553 | |
| DEPICLICSLSQEHQ | 391 | O15553 | |
| LCNLCPDRANKEHIL | 81 | Q9H6L4 | |
| CAEDLAHCQSNLVEL | 261 | Q9BZF3 | |
| AICPLEELCDVSHQY | 336 | P22557 | |
| EPCQDLTFTNLDALH | 441 | Q7RTS6 | |
| LCQEALNAERELCHP | 236 | Q5VYJ5 | |
| CPSLLLDHADVVNCT | 1396 | Q9BXP8 | |
| CEPIIQNFCHDVADN | 696 | Q92896 | |
| CCQALEISLDQEHIP | 4521 | Q4G0P3 | |
| PFCQAHLCEETTNRL | 16 | Q9P1J3 | |
| LLELAQQDHGALDCC | 216 | P55211 | |
| PEVCHLQEADVIFLC | 996 | A8TX70 | |
| LDCQEQHCEQGLSLD | 3746 | Q8TDW7 | |
| LPQEANLCFVDIDNH | 361 | Q6ZUT9 | |
| LPQEANLCFVDIDNH | 376 | Q6IQ26 | |
| CHNIPCEEGDKLQLF | 351 | Q16666 | |
| PKCQELRHLCDQFSA | 431 | O15068 | |
| CAEFLEKNLHPTNCL | 136 | O14682 | |
| KCPLCRNDIHEDNLL | 796 | Q14527 | |
| QLELIDLSSNPFHCD | 666 | Q6NUI6 | |
| LNIDECFSNPCIHGN | 1176 | P82279 | |
| DPDSQHCRDVNECLT | 46 | O95967 | |
| NLLFDLVCHEFCQSD | 296 | Q96ER3 | |
| CLENQLPAFLEELCH | 86 | P02771 | |
| LPRHQLLCFKEDCQA | 361 | Q9UJX0 | |
| DFPDAYCNLAHCLQI | 461 | O15294 | |
| QPLDNELICIAEHCT | 351 | Q9UKT6 | |
| DLDETIQPCHSLCVQ | 106 | Q96HF1 | |
| YEDVHTNPDQDCCLL | 281 | Q1AE95 | |
| CAHDQLEVIELDNCP | 351 | Q96IG2 | |
| CNTPLQFELCHRKDL | 901 | Q9C0A6 | |
| VPNGASLEDCHCNLF | 6 | Q9UHV7 | |
| FLCPLQDVCASLQED | 486 | Q96M02 | |
| ELNLCQHEAKCIPLD | 1041 | O75094 | |
| EAVQCLHALEEYCPS | 116 | O94967 | |
| DQCDNCPLEHNPDQL | 831 | P07996 | |
| YEDVHTNPDQDCCLL | 281 | Q8IXX5 | |
| ILEEQCLVPDSSHCQ | 2126 | P04275 | |
| HQLVDQCCNAEALPV | 231 | Q9BR01 | |
| TDIPCLLYDDNLFCH | 386 | Q6NUQ1 | |
| LQLCLEHSLADCNDI | 41 | Q5PRF9 | |
| EHADCVLPIDNQSLF | 201 | Q9UJT0 | |
| SDDFLHCAIDCLNLA | 361 | C9JR72 | |
| QGEPLHFCCLDFSLE | 191 | Q8WZ71 | |
| CIQDCNRALELHPFS | 506 | Q07617 | |
| GETNEHSECFLNPCL | 436 | Q9NQB0 | |
| LHQQLQDCFSISDCP | 121 | O75191 | |
| KLDFCAQDLNPCQHD | 1036 | O94813 | |
| CEEHLDPLSIYCEQD | 86 | Q6ZMU5 | |
| ADCLLHEENFSVRCP | 1916 | Q9UGU0 | |
| TCEQPLQCEIFHQLG | 1076 | Q8IUG5 | |
| LNVFHCQEECVSLDP | 121 | P98182 | |
| HNQICELPARLFCNS | 926 | O60346 | |
| CCHLASLQELVDPQA | 226 | P57081 | |
| QCIHCPEVFVDENTL | 296 | Q2M1K9 | |
| LAHPDICCISEILDQ | 1981 | Q9BXT5 | |
| DCNFSDLDICTIIPH | 421 | O15050 | |
| IQTLHLAQNPFICDC | 431 | O75093 | |
| EAELCPDRCIHSFQN | 101 | Q04206 | |
| TACLQPTLDVFCHED | 116 | A8MYJ7 | |
| LLLQCDCQDHPRSLD | 181 | O43156 | |
| DQRPHKCDICEQSFE | 191 | Q8IZ26 | |
| EECRDEKPHALQACN | 741 | P82987 | |
| CEFLESQLHPVNCLG | 146 | O95198 | |
| CDVFRHPSCNLQDLE | 921 | Q86W24 | |
| CRPAAEALLCNHIFQ | 366 | O15146 | |
| EALLCNHIFQECSPG | 371 | O15146 |